Effect of Serum Magnesium Level on the Success of Transforaminal Epidural Steroid Injection

Launched by KANUNI SULTAN SULEYMAN TRAINING AND RESEARCH HOSPITAL · Aug 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how the level of magnesium in the blood might affect the success of a treatment called transforaminal epidural steroid injection (TFESE). This treatment is often used for people experiencing back pain due to issues like a herniated disc. TFESE involves injecting steroids and local anesthetics near the affected nerves to reduce inflammation and pain. The researchers want to see if having enough magnesium in the body can improve the effectiveness of this treatment, especially since low magnesium levels can be linked to increased back pain.

To participate in this trial, individuals must be between the ages of 65 and 74 and not have certain medical conditions, like fibromyalgia or metabolic diseases, that could interfere with the study. Participants should not be taking magnesium or calcium supplements and should not have a history of lumbar surgery. Those who qualify will receive the TFESE treatment and will be monitored for three months to see how well it works for them. This study aims to improve pain management strategies for patients suffering from back pain by understanding the role of magnesium better.

Gender

ALL

Eligibility criteria

• Exclusion Criteria:
• • Patients whose medical analgesic treatment was changed during their three-month follow-up;
• • Those with fibromyalgia;
• • Those with metabolic diseases (chronic renal failure, spondyloarthropathies, diabetes, hypo/hyperthyroidism, etc.) that may affect serum magnesium level;
• • Those with a history of lumbar surgery;
• • those taking magnesium or calcium supplements;
• • Those with malignancy or obesity;
• • Those with psychiatric illness;
• • Those without lumbar MRI; Patients whose clinical, physical examination and laboratory data cannot be accessed